Cargando…
Advancing large-scale production of TEV protease through an innovative NT* tag-based fusion construct
Tobacco etch virus Protease (TEVp), a cysteine protease, is renowned for its remarkable specific proteolysis, making it an invaluable tool for removing fusion tags from recombinant proteins. However, TEV protease's inherent insolubility limits its broad application. Fusion constructs like an N-...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563009/ https://www.ncbi.nlm.nih.gov/pubmed/37822550 http://dx.doi.org/10.1016/j.crstbi.2023.100106 |
_version_ | 1785118253103710208 |
---|---|
author | Parida, Pragyan P. Saraswathi, Deepa Mopidevi, Subbarao M.V. Raran-Kurussi, Sreejith |
author_facet | Parida, Pragyan P. Saraswathi, Deepa Mopidevi, Subbarao M.V. Raran-Kurussi, Sreejith |
author_sort | Parida, Pragyan P. |
collection | PubMed |
description | Tobacco etch virus Protease (TEVp), a cysteine protease, is renowned for its remarkable specific proteolysis, making it an invaluable tool for removing fusion tags from recombinant proteins. However, TEV protease's inherent insolubility limits its broad application. Fusion constructs like an N-terminal MBP fusion, known for its improved solubility, have been employed for TEVp production to address this issue. In this study, we fused the TEVp with the N-terminal domain of the spider silk protein, specifically utilizing a charge-reversed mutant (D40K/K65D) of the N-terminal domain of major ampullate spidroin-1 protein from Euprosthenops australis, referred to as NT*. This fusion construct contains a TEVp cleavage site, enabling intracellular self-processing and the release of a His(7)-tagged protease. The significant increase in soluble protein expression allowed us to purify approximately 90–100 mg of TEVp from a 1-L E. coli culture, surpassing previous findings by a considerable margin. The enzyme remained stable and catalytically active even after several months of storage in a deep freezer (−80 °C). |
format | Online Article Text |
id | pubmed-10563009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105630092023-10-11 Advancing large-scale production of TEV protease through an innovative NT* tag-based fusion construct Parida, Pragyan P. Saraswathi, Deepa Mopidevi, Subbarao M.V. Raran-Kurussi, Sreejith Curr Res Struct Biol Short Communication Tobacco etch virus Protease (TEVp), a cysteine protease, is renowned for its remarkable specific proteolysis, making it an invaluable tool for removing fusion tags from recombinant proteins. However, TEV protease's inherent insolubility limits its broad application. Fusion constructs like an N-terminal MBP fusion, known for its improved solubility, have been employed for TEVp production to address this issue. In this study, we fused the TEVp with the N-terminal domain of the spider silk protein, specifically utilizing a charge-reversed mutant (D40K/K65D) of the N-terminal domain of major ampullate spidroin-1 protein from Euprosthenops australis, referred to as NT*. This fusion construct contains a TEVp cleavage site, enabling intracellular self-processing and the release of a His(7)-tagged protease. The significant increase in soluble protein expression allowed us to purify approximately 90–100 mg of TEVp from a 1-L E. coli culture, surpassing previous findings by a considerable margin. The enzyme remained stable and catalytically active even after several months of storage in a deep freezer (−80 °C). Elsevier 2023-09-30 /pmc/articles/PMC10563009/ /pubmed/37822550 http://dx.doi.org/10.1016/j.crstbi.2023.100106 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Short Communication Parida, Pragyan P. Saraswathi, Deepa Mopidevi, Subbarao M.V. Raran-Kurussi, Sreejith Advancing large-scale production of TEV protease through an innovative NT* tag-based fusion construct |
title | Advancing large-scale production of TEV protease through an innovative NT* tag-based fusion construct |
title_full | Advancing large-scale production of TEV protease through an innovative NT* tag-based fusion construct |
title_fullStr | Advancing large-scale production of TEV protease through an innovative NT* tag-based fusion construct |
title_full_unstemmed | Advancing large-scale production of TEV protease through an innovative NT* tag-based fusion construct |
title_short | Advancing large-scale production of TEV protease through an innovative NT* tag-based fusion construct |
title_sort | advancing large-scale production of tev protease through an innovative nt* tag-based fusion construct |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563009/ https://www.ncbi.nlm.nih.gov/pubmed/37822550 http://dx.doi.org/10.1016/j.crstbi.2023.100106 |
work_keys_str_mv | AT paridapragyanp advancinglargescaleproductionoftevproteasethroughaninnovativenttagbasedfusionconstruct AT saraswathideepa advancinglargescaleproductionoftevproteasethroughaninnovativenttagbasedfusionconstruct AT mopidevisubbaraomv advancinglargescaleproductionoftevproteasethroughaninnovativenttagbasedfusionconstruct AT rarankurussisreejith advancinglargescaleproductionoftevproteasethroughaninnovativenttagbasedfusionconstruct |